SIOG – International Society of Geriatric Oncology shared a post on LinkedIn:
“New in JGO.
Geriatric co-management in older adults starting cancer treatment.
Can geriatric co-management improve outcomes for older patients initiating systemic therapy?
In this randomized trial of patients aged 70+ with geriatric vulnerabilities, co-management did not significantly improve independence or quality of life at 12 weeks. However, it was associated with lower rates of severe toxicity and fewer unplanned hospitalisations compared with standard care.
These findings support the role of multidisciplinary approaches in managing older adults with cancer.
SIOG members enjoy free online access to JGO.”
Title: Effect of geriatric co-management on independence, quality of life, and severe toxicity in vulnerable older patients with cancer: Results of a randomized clinical trial
Authors: Gabriele Ihorst, Elisabeth Jentschke, Kathrin Tatschner, Carmen Roch, Birgitt van Oorschot, Peter Baier, Bernhard Geyer, Miriam Hüttmeyer, Christoph Hohlbein, Anna Heckers, Johanna Gerber, Barbara Deschler-Baier
Read The Full Article
Other articles about SIOG on OncoDaily.